Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

257 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma.
Qazilbash MH, Saliba RM, Hosing C, Mendoza F, Qureshi SR, Weber DM, Wang M, Flosser T, Couriel DR, De Lima M, Kebriaei P, Popat U, Alousi AM, Champlin RE, Giralt SA. Qazilbash MH, et al. Among authors: giralt sa. Bone Marrow Transplant. 2007 Mar;39(5):279-83. doi: 10.1038/sj.bmt.1705580. Epub 2007 Jan 29. Bone Marrow Transplant. 2007. PMID: 17262062 Clinical Trial.
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis.
Khoury HJ, Kukreja M, Goldman JM, Wang T, Halter J, Arora M, Gupta V, Rizzieri DA, George B, Keating A, Gale RP, Marks DI, McCarthy PL, Woolfrey A, Szer J, Giralt SA, Maziarz RT, Cortes J, Horowitz MM, Lee SJ. Khoury HJ, et al. Among authors: giralt sa. Bone Marrow Transplant. 2012 Jun;47(6):810-6. doi: 10.1038/bmt.2011.194. Epub 2011 Oct 10. Bone Marrow Transplant. 2012. PMID: 21986636 Free PMC article. Clinical Trial.
Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas.
Khouri IF, Saliba RM, Hosing C, Okoroji GJ, Acholonu S, Anderlini P, Couriel D, De Lima M, Donato ML, Fayad L, Giralt S, Jones R, Korbling M, Maadani F, Manning JT, Pro B, Shpall E, Younes A, McLaughlin P, Champlin RE. Khouri IF, et al. J Clin Oncol. 2005 Apr 1;23(10):2240-7. doi: 10.1200/JCO.2005.08.012. J Clin Oncol. 2005. PMID: 15800314 Clinical Trial.
Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis.
Cho C, Hsu M, Barba P, Maloy MA, Avecilla ST, Barker JN, Castro-Malaspina H, Giralt SA, Jakubowski AA, Koehne G, Meagher RC, O'Reilly RJ, Papadopoulos EB, Ponce DM, Tamari R, van den Brink MRM, Young JW, Devlin SM, Perales MA. Cho C, et al. Among authors: giralt sa. Bone Marrow Transplant. 2017 Dec;52(12):1629-1636. doi: 10.1038/bmt.2017.197. Epub 2017 Oct 9. Bone Marrow Transplant. 2017. PMID: 28991247 Free PMC article.
High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to neoadjuvant chemotherapy.
Ueno NT, Konoplev S, Buchholz TA, Smith T, Rondón G, Anderlini P, Giralt SA, Gajewski JL, Donato ML, Cristofanilli M, Champlin RE. Ueno NT, et al. Among authors: giralt sa. Bone Marrow Transplant. 2006 May;37(10):929-35. doi: 10.1038/sj.bmt.1705355. Bone Marrow Transplant. 2006. PMID: 16565737 Clinical Trial.
257 results